Home › Trial NCT01428440
PET Study to Study Tumour Apoptosis
- Trial IDNCT01428440
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorGlaxoSmithKline
- Enrollment7
- Start date2009-12
- ConditionsCancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.